The listed company Square Pharmaceuticals plc has declared dividend for the financial year ended on June 30, 2024. The company will pay 110 percent dividend to shareholders for the year under review. It’s all cash.
This decision of dividend was taken after reviewing and approving the audited financial report of the last financial year in the meeting of the board of directors of the company held today, Wednesday (October 23).
According to sources, the company’s consolidated earnings per share (EPS) stood at Tk. 23.61 paise during the year under review. The company’s consolidated EPS for the previous year was Tk 21.41 paise.
As on June 30, 2024, the company’s consolidated net asset value per share (NAVPS) was Tk. 142.05 paise.
The annual general meeting of the company will be held on December 18 through the digital platform. The record date for this has been fixed on November 21.
This information is known from company sources.

